Retatrutide + Cagrilintide

5+5 mg is a late stock, not a first injection.

What it does / how it works

Triple incretin/glucagon agonist plus amylin. Three appetite/energy pathways plus a fourth fullness signal. High GI load.

Class Blend · RC10 · 5 mg + 5 mg
Typical vial 10 mg total
Reconstitution 2 mL BAC = 2.5 mg/mL of each.
Storage after mix 2–8°C, use within 28 days

Protocol

Goal Dose How often How long Route
Weeks 1-4 Retatrutide 1 mg + Cagrilintide 1 mg Once weekly 4 weeks SubQ
Weeks 5-8 Retatrutide 2 mg + Cagrilintide 2 mg Once weekly 4 weeks SubQ
Do not start here 5 mg + 5 mg Once weekly Not a start dose SubQ

Watch: Additive nausea.

Retatrutide + Cagrilintide FAQ — Australia

Conceptually similar to stacking a GLP-axis agonist with an amylin analogue (CagriSema logic) but one arm is an unapproved triple agonist.

Recommended Supplier — Retatrutide + Cagrilintide Australia

Our products offer premium-grade research materials with independent testing at a leading Australian university. Every batch is strictly verified by RP-HPLC and LC-MS. For research purposes only.

Related Research — Australia

Explore similar research-grade peptides, selected to complement your research needs.

Tesamorelin + Ipamorelin

Tesamorelin target is 1-2 mg daily. Ipamorelin target....

Super Human Blend

One serving: L-Arginine 110 mg, L-Ornithine 110 mg,....

Semax + Selank

Short course. Intranasal preferred. Then 2-4 weeks off.....

SS-31 + MOTS-c

1:1 pair. 5 mg + 5 mg per....
Select your currency
AUD Australian dollar